Ultra-Low Sample Optimized Mass Spectrometer

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology, July 2023
Volume 47
Issue 7
Pages: 12

Bruker Corporations timsTOF Ultra mass spectrometer features a captive spray ionization ino sources that provides optimized vortex gas flow.

Bruker Corporations timsTOF Ultra

Bruker Corporations timsTOF Ultra

Bruker’s timsTOF Ultra mass spectrometer is designed for use with the company’s 4D-proteomics timsTOF platform. The device uses a new captive spray ionization ion source that provides a larger capillary relative to past models as well as optimized vortex gas flow.

The device is designed to identify over 55,000 peptides that map into 5000 protein groups at the single-cell level of 0.125 nanogram protein loading at less than 1% false discovery rate. More than 4800 protein groups are quantified at a coefficient of variation of less than 20%.

The parallel accumulation-serial fragmentation duty cycle can go as fast as 300 Hz for tandem mass spectrometry, which is intended to provide performance improvements for processes involving ultra-low sample amounts. This includes unbiased single-cell proteomics and single-cell lipidomics, unbiased spatial proteomics, immunopeptidomics, phosphoproteomics, post-translational modification analysis, and protein–protein interaction studies.

Bruker

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Related Content